What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read General business news Lilly to expand into cardiovascular gene editing with Verve Therapeutics acquisition Eli Lilly’s $1.3B acquisition of Verve Therapeutics targets breakthrough one-time gene therapies for high-risk cardiovascular patients. Read more. byPallavi MadhirajuJune 17, 2025